Holen Sie sich die Stockscreener-App
0.538
5.40%
-0.0307
Handel nachbörslich:
.54
0.002
+0.37%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMRA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.5687
Offen:
$0.578
24-Stunden-Volumen:
124.85K
Relative Volume:
0.02
Marktkapitalisierung:
$9.87M
Einnahmen:
$5.51M
Nettoeinkommen (Verlust:
$-6.16M
KGV:
-1.4541
EPS:
-0.37
Netto-Cashflow:
$-5.03M
1W Leistung:
-13.09%
1M Leistung:
-24.47%
6M Leistung:
+63.03%
1J Leistung:
-35.52%
1-Tages-Spanne:
$0.51
$0.5892
1-Wochen-Bereich:
$0.51
$0.6394
52-Wochen-Spanne:
$0.2415
$1.27
Biomerica Inc Stock (BMRA) Company Profile
Firmenname
Biomerica Inc
Sektor
Branche
Telefon
(949) 379-2875
Adresse
17571 VON KARMAN AVENUE, IRVINE, CA
Vergleichen Sie BMRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
0.538 | 9.87M | 5.51M | -6.16M | -5.03M | -0.37 |
|
ABT
Abbott Laboratories
|
131.63 | 228.29B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
98.50 | 145.69B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
368.15 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.89 | 112.70B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.98 | 42.75B | 5.72B | 4.17B | 259.90M | 6.97 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-10 | Eingeleitet | Colliers Securities | Buy |
| 2018-01-04 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Biomerica Inc Aktie (BMRA) Neueste Nachrichten
Enteric Disease Testing Market Set to Witness Significant - openPR.com
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 65.5% in March - Defense World
Biomerica (NASDAQ:BMRA) Share Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Grows By 64.6% - Defense World
Biomerica’s tests for IBD conditions gain CE-marking under EU’s IVDR - Yahoo
Biomerica gains EU certification for IBD food intolerance products By Investing.com - Investing.com South Africa
Biomerica gains EU certification for IBD food intolerance products - Investing.com India
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis - The Manila Times
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests ... - The Bakersfield Californian
Can Biomerica's Newly Certified IBD Tests Transform Crohn's and Colitis Management in Europe? - StockTitan
Biomerica (NASDAQ:BMRA) Stock Quotes, Forecast and News Summary - Benzinga
Biomerica reports Q2 EPS (6c) vs. (9c) last year - MSN
Biomerica'S Infoods® IBS Clinical Trial Results Published And Featured In Gastroenterology, The Leading Gi Medical Journal - Marketscreener.com
Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal - The Manila Times
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the - The Bakersfield Californian
Revolutionary IBS Test Achieves 67% Success RateCould This End Restrictive Diets? - StockTitan
BMRA’s 2023 Market Dance: Up 131.89% – Time to Invest? - The InvestChronicle
Biomerica Inc (BMRA) Stock Experiences 117.62% Monthly Change - The News Heater
Will Biomerica Inc (BMRA) meet earnings estimates this quarter? - US Post News
Biomerica Inc (BMRA)’s stock rises to 0.51 per share - US Post News
Financial Fitness Check: Examining Biomerica Inc (BMRA)’s Key Ratios - The Dwinnex
Midday Stock Roundup: Lantronix Shares Drop 23% - Orange County Business Journal
Investor Ideas - Investorideas.com newswire
Blood Testing Market is anticipated to reach $173.59 billion by 2032, exhibiting a CAGR of 7.88% - openPR
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Biomerica’s prostate cancer detection test gains approval from MOHAP - MSN
Biomerica's rapid PSA test gains UAE approval - MSN
23. Weekly Market Recap: Key Movements & Insights - substack.com
Smith & Nephew (SNN) Stock Surges Amid Strong Financial Performa - GuruFocus.com
Biomerica Adds Most New Retail Followers Among Biotechs After UAE Nod For Prostate Cancer Screening Test - MSN
January 2025 US Penny Stocks With Promising Potential - Simply Wall St
Philip Morris International Inc. (PM): A Bull Case Theory - Yahoo Finance
Does Apple owe you money for issues with Siri? What to know about the $95M settlement - Yahoo! Voices
Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates - Benzinga
AAPL, RIVN, UNH, BMRA, TSLA: Top 5 Trending Stocks TodayApple (NASDAQ:AAPL), Biomerica (NASDAQ:BMRA) - Benzinga
Why Rumble Inc. (RUM) Is Skyrocketing - Yahoo Finance
Why IonQ, Inc. (IONQ) Is Skyrocketing - Yahoo Finance
AVLV Has $254.7M in Inflows - Yahoo! Voices
Riot Platforms, Inc. (RIOT) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Trump's US Treasury pick says question of debt limit repeal is 'nuanced' - Yahoo! Voices
Orion Office REIT Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release and Webcast Dates - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
King Soopers, Colorado UFCW staring at contract deadline - Yahoo News
Here’s Why Magnite, Inc. (MGNI) Is Gaining Momentum From Key Collaborations - Yahoo Finance
Goldman Sachs may cut Apple Card partnership short - Yahoo! Voices
Biomedical Stock Biomerica Inc. (NASDAQ: BMRA) Makes NASDAQ TOP Gainer List on UAE Ministry of Health and Prevention Approval - Investorideas.com newswire
Microsoft to now include Copilot in Microsoft 365 for consumers - Yahoo! Voices
BK Technologies Corporation (BKTI): A Bull Case Theory - Yahoo Finance
Freshworks, Flowco, Target - TradingView
Norway’s Berge Rederi selects Norsepower Rotor Sails for cargo vessels - Yahoo News
Private label sales hit record $271B in 2024 - Yahoo News
Finanzdaten der Biomerica Inc-Aktie (BMRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.71%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):